- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05051371
Postoperative Residual Curarization in Elderly Patients in Post-anesthesia Care Unit
Incidence of Postoperative Residual Curarization in Elderly Patients in the Post-anesthesia Care Unit, and Attitude and Awareness Questionnaire of Anesthesiologists
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Postoperative residual curarization (PORC) after general anesthesia is an important complication that can cause adverse patient outcomes, including symptoms of airway obstruction, hypoxia, respiratory distress, muscle weakness, and dyspnea in the early and late stages.
Anticholinesterase agents are commonly used to reverse neuromuscular blockade. Even with the use of anticholinesterase, severe PORC can be seen. The use of anticholinesterases in elderly patients is controversial due to the high side-effect profile.
Sugammadex, which has been widely used with its approval by the United States Food and Drug Administration in 2015, is a reverse agent that acts through a different mechanism than traditional anticholinesterase agents (it is a cyclodextrin molecule that encapsulates steroid neuromuscular blockers). Compared to neostigmine, sugammadex reverses neuromuscular blockade faster and more reliably.
In this study, we aimed to determine the knowledge levels and approaches of anesthesiologists working in our clinic about postoperative residual curarization(PORC) in elderly patients with a questionnaire. In addition, we aimed to determine the incidence of PORC and factors associated with PORC in the recovery unit in elderly patients over 65 years of age who underwent surgery under general anesthesia using muscle relaxants with a prospective observational study.
The first phase of the study is a prospective observational study. Elderly patients (>65) who are scheduled to undergo elective surgery under general anesthesia and require intubation using muscle relaxants will be screened for PORC using Train of four monitor in the recovery unit.
In the second phase of the study, an online questionnaire with 15 questions will determine the knowledge and attitudes of anesthesiologists working in our clinic on the use of muscle relaxants and reversing agents in elderly patients, the use of neuromuscular monitoring and PORC.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Aysun Postaci
- Phone Number: +90 5323520383
- Email: aysunposta@yahoo.com
Study Locations
-
-
-
Ankara, Turkey, 06800
- Recruiting
- Ankara City Hospital
-
Contact:
- Aysun Postaci, As.Prof.Dr.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- age >65
- general anesthesia using non-depolarizing neuromuscular blocker
Exclusion Criteria:
- Patients with an ASA score greater than 3
- Those with contraindications to anesthetic drugs
- Those with neuromuscular, neurological and psychiatric diseases
- Patients in whom TOF monitoring is not possible in the ulnar nerve region
- Patients with advanced renal failure
- Patients with advanced hepatic insufficiency
- Those with decompensated heart failure
- Patients with BMI<18 and BMI>30
- Patients with uncontrolled hypertension, uncontrolled diabetes, pheochromocytoma, thyroid dysfunction
- Those who are incapable of reading and signing the consent form
- Patients who do not want to sign the consent form
- Patients deemed unsuitable by the investigator
- Those with chronic opioid use
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The incidence of postoperative residual curarization
Time Frame: through study completion( anticipated 5 months)
|
The incidence of elderly patients that Train of Four(TOF) rate <0.9 in the postoperative care unit
|
through study completion( anticipated 5 months)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Aysun Postaci, Ankara City Hospital Bilkent
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- E1-21-1912
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postoperative Residual Curarization
-
Peking University First HospitalXiangya Hospital of Central South University; Peking Union Medical College... and other collaboratorsUnknownPerioperative/Postoperative Complications | PORC (Postoperative Residual Curarization)China
-
Iuliu Hatieganu University of Medicine and PharmacyUnknownIncidence of Postoperative Residual Curarization
-
Xinmin WuMerck Sharp & Dohme LLCCompletedResidual CurarizationChina
-
University Hospital, CaenNot yet recruitingCurarization, Postoperative ResidualFrance
-
Fondazione Policlinico Universitario Agostino Gemelli...Completed
-
Poitiers University HospitalCompletedNeuromuscular Residual CurarizationFrance
-
University of Colorado, DenverCompletedPostoperative Residual Curarization | Kidney Transplant; Complications | Postoperative Residual WeaknessUnited States
-
Beth Israel Deaconess Medical CenterCompletedPostoperative Respiratory Complication | Residual Neuromuscular Blockade | Curarization, Postoperative ResidualUnited States
-
Azienda Ospedaliera di PadovaCompletedPostoperative Residual Curarization | Residual Neuromuscular BlockItaly
-
Peking Union Medical College HospitalNot yet recruitingPostoperative Pulmonary Complications
Clinical Trials on Train of four monitoring
-
Centre Chirurgical Marie LannelongueCompletedAcute Respiratory Distress SyndromeFrance
-
Mayo ClinicCompletedNeuromuscular BlockadeUnited States
-
Poitiers University HospitalCompletedPostoperative Residual CurarizationFrance
-
NorthShore University HealthSystemT4 AnalyticsTerminatedResidual Neuromuscular BlockadeUnited States
-
University of MinnesotaWithdrawnObservation of Neuromuscular Block
-
Air Force Military Medical University, ChinaCompleted
-
NYU Langone HealthCompletedMuscle Relaxation | Neuromuscular BlockadeUnited States
-
Ankara City Hospital BilkentNot yet recruitingNeuromuscular Blockade | Neuromuscular Monitoring | Statin-Associated Myopathy
-
Dr. Negrin University HospitalRecruitingResidual Neuromuscular Block in the Post-Anesthetic Unit and Postoperative Complications (Porcerito)Postoperative Complications | Postoperative Neuromuscular BlockSpain
-
Ankara City Hospital BilkentNot yet recruitingRocuronium | Rapid Sequence Induction | Rapid Sequence IntubationTurkey